Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Shares Issued (2020 - 2025)

Roivant Sciences (ROIV) has disclosed Shares Issued for 5 consecutive years, with $381000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued fell 41.2% year-over-year to $381000.0, compared with a TTM value of $1.8 million through Dec 2025, down 82.19%, and an annual FY2024 reading of $199.8 million, down 35.95% over the prior year.
  • Shares Issued was $381000.0 for Q4 2025 at Roivant Sciences, up from -$29.3 million in the prior quarter.
  • Across five years, Shares Issued topped out at $178.8 million in Q3 2023 and bottomed at -$29.3 million in Q3 2025.
  • Average Shares Issued over 4 years is $21.2 million, with a median of $1.5 million recorded in 2024.
  • Peak annual rise in Shares Issued hit 1223.51% in 2025, while the deepest fall reached 542.34% in 2025.
  • Year by year, Shares Issued stood at $569000.0 in 2022, then increased by 3.16% to $587000.0 in 2023, then rose by 10.39% to $648000.0 in 2024, then tumbled by 41.2% to $381000.0 in 2025.
  • Business Quant data shows Shares Issued for ROIV at $381000.0 in Q4 2025, -$29.3 million in Q3 2025, and $30.1 million in Q2 2025.